Mail Icon info@synchemia.com | sales@synchemia.com Phone Icon 9766925136
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
Mail Icon info@synchemia.com | sales@synchemia.com Phone Icon 9766925136
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

search icon
home icon Home > API Impurities > Anastrozole > Anastrozole EP Impurity E

Anastrozole EP Impurity E

Chemical Structure
Specifications
Product name
Anastrozole EP Impurity E
SRC CAT No
SRC-A27466
CAS No
120511-88-8
Mol.F.
C15H18N2O
Mol.Wt.
242.3g/mole
Related CAS No.
1015083-82-5 (Na salt)
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Chemical Structure
view file icon VIEW COA
Product Overview
Description
Chemical Name
2,2′-[5-(Hydroxymethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)

HSN Code
38229010
Synonym
N.A

Synchemia is a leading supplier in pharmaceutical Anastrozole Impurities. Anastrozole is used to treat early hormone receptor-positive breast cancer. It is also used for first-line treatment of hormone receptor-positive or hormone receptor-unknown advanced or metastatic (cancer that has spread) breast cancer.

Anastrozole EP Impurity E CAS NO: 120511-88-8 chemically represented as 2,2′-[5-(Hydroxymethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile).Synchemia is the leading supplier and exporter Anastrozole EP Impurity E .We supply Anastrozole EP Impurity E with detailed characterization data compliance with regulatory guidelines.